Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives $583.83 Consensus PT from Brokerages

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have been assigned an average recommendation of “Moderate Buy” from the twenty-one brokerages that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $613.10.

ISRG has been the subject of a number of research reports. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Raymond James lifted their target price on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Stifel Nicolaus lifted their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. Leerink Partners lifted their target price on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday. Finally, Bernstein Bank lifted their target price on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at $1,502,019.30. The trade was a 3.45 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 28,843 shares of company stock valued at $15,357,560. Corporate insiders own 0.90% of the company’s stock.

Institutional Trading of Intuitive Surgical

Several large investors have recently added to or reduced their stakes in the company. Mirador Capital Partners LP grew its holdings in shares of Intuitive Surgical by 1.4% during the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after acquiring an additional 50 shares in the last quarter. M.E. Allison & CO. Inc. purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at $449,000. Seilern Investment Management Ltd purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at $82,517,000. Exome Asset Management LLC grew its holdings in shares of Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after acquiring an additional 1,069 shares in the last quarter. Finally, Consolidated Planning Corp grew its holdings in shares of Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after acquiring an additional 1,198 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Down 0.2 %

Shares of Intuitive Surgical stock opened at $572.71 on Monday. The business has a 50-day moving average price of $548.70 and a 200 day moving average price of $507.04. Intuitive Surgical has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm has a market cap of $203.99 billion, a P/E ratio of 92.08, a P/E/G ratio of 5.19 and a beta of 1.39.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.